Allworth Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Allworth Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.11K	Sell	137 -2	-1%	-$66	﹤0.01%	4067
2025 Q4	$4.55K	Sell	139 -44	-24%	-$1.42K	﹤0.01%	3770
2025 Q3	$6.34K	Buy	183 +48	+36%	+$1.53K	﹤0.01%	3407
2025 Q2	$3.78K	Buy	135 +126	+1,400%	+$3.38K	﹤0.01%	3419
2025 Q1	$239	Sell	9 -12	-57%	-$303	﹤0.01%	3835
2024 Q4	$503	Sell	21 -118	-85%	-$3.29K	﹤0.01%	3599
2024 Q3	$4K	Sell	139 -16	-10%	-$436	﹤0.01%	2667
2024 Q2	$4.05K	Buy	+155	New	+$4.4K	﹤0.01%	2606
2021 Q1	–	Sell	-1	Closed	–	–	1540
2020 Q4	$0	Buy	+1	New	+$122	﹤0.01%	1381

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allworth Financial's LKFT Position: Q1 2026 in Review

Allworth Financial reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 1.4% in Q1 2026, selling an estimated $66 and leaving 137 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4067.

Allworth Financial first reported a position in LKFT in Q4 2020 and has held it in 9 quarters since. The position peaked at $6.34K in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Allworth Financial held 137 shares of Lakefront Biotherapeutics American Depositary Shares worth $4.11K as of Q1 2026.
Allworth Financial sold 2 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $66.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4067 holding.
Allworth Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and has held it in 9 quarters since.
Allworth Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $6.34K in Q3 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.